FDA Changes leaflets of antipsychotics
in the package inserts of all antipsychotics are updated the passages on the pregnancy.
In all antipsychotics in the U.S. now pointed in the package insert that can be increased when taken during pregnancy, the risk of extrapyramidal syndrome and that have taken in newborns of mothers who antipsychotics in the third trimester of pregnancy, you may experience withdrawal symptoms.
Source: FDA Safety Information
of 22 February 2011
0 comments:
Post a Comment